1 North Wealth Services’s AstraZeneca AZN Stock Holding History

1 North Wealth Services’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.8K	Buy	120 +13	+12%	+$2.44K	0.01%	130
2026 Q1	$21.1K	Sell	107 -1	-0.9%	-$193	0.01%	120
2025 Q4	$19.8K	Hold	108	–	–	0.01%	127
2025 Q3	$16.5K	Hold	108	–	–	0.01%	124
2025 Q2	$15K	Hold	108	–	–	0.01%	128
2025 Q1	$15.8K	Buy	+108	New	+$15.6K	0.01%	126

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

1 North Wealth Services's AZN Position: Q2 2026 in Review

1 North Wealth Services increased its AstraZeneca (AZN) stake by 12% in Q2 2026, buying an estimated $2.44K and bringing the position to 120 shares worth $22.8K. The position accounts for 0.01% of the portfolio, ranked #130.

1 North Wealth Services first reported a position in AZN in Q1 2025 and has held it in 6 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

1 North Wealth Services held 120 shares of AstraZeneca worth $22.8K as of Q2 2026.
1 North Wealth Services bought 13 AstraZeneca shares in Q2 2026, an estimated $2.44K.
AstraZeneca made up 0.01% of 1 North Wealth Services's portfolio in Q2 2026, its #130 holding.
1 North Wealth Services first reported a position in AstraZeneca in Q1 2025 and has held it in 6 quarters since.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on 1 North Wealth Services's 13F filing for Q2 2026, filed 3 Aug 2026.